-
1
-
-
0026500785
-
Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group
-
Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 1992;10:282-291.
-
(1992)
J Clin Oncol
, vol.10
, pp. 282-291
-
-
Roth, B.J.1
Johnson, D.H.2
Einhorn, L.H.3
-
2
-
-
0029067170
-
Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: An Eastern Cooperative Oncology Group pilot study
-
Wolff AC, Ettinger DS, Neuberg D, et al. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study. J Clin Oncol 1995;13:1615-1622.
-
(1995)
J Clin Oncol
, vol.13
, pp. 1615-1622
-
-
Wolff, A.C.1
Ettinger, D.S.2
Neuberg, D.3
-
3
-
-
0021971351
-
Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up
-
Johnson BE, Ihde DC, Bunn PA, et al. Patients with small-cell lung cancer treated with combination chemotherapy with or without irradiation. Data on potential cures, chronic toxicities, and late relapses after a five- to eleven-year follow-up. Ann Intern Med 1985;103:430-438.
-
(1985)
Ann Intern Med
, vol.103
, pp. 430-438
-
-
Johnson, B.E.1
Ihde, D.C.2
Bunn, P.A.3
-
4
-
-
0024411271
-
Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus
-
Thatcher N, Lind M, Stout R, et al. Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchus. Br J Cancer 1989;60:98-101.
-
(1989)
Br J Cancer
, vol.60
, pp. 98-101
-
-
Thatcher, N.1
Lind, M.2
Stout, R.3
-
5
-
-
0032414054
-
Modified ice study: A phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer
-
Shevlin PM, Muers MF, Peake MD, et al. Modified ice study: a phase II study of an intensive, modified ICE regimen (ifosfamide, carboplatin and etoposide) in patients with better prognosis, small cell lung cancer. Lung Cancer 1998;21:115-126.
-
(1998)
Lung Cancer
, vol.21
, pp. 115-126
-
-
Shevlin, P.M.1
Muers, M.F.2
Peake, M.D.3
-
6
-
-
0029164627
-
Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer
-
Lorigan P, Lee SM, Betticher D, et al. Chemotherapy with vincristine/ifosfamide/carboplatin/etoposide in small cell lung cancer. Semin Oncol 1995;22:32-41.
-
(1995)
Semin Oncol
, vol.22
, pp. 32-41
-
-
Lorigan, P.1
Lee, S.M.2
Betticher, D.3
-
7
-
-
0033901542
-
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: Results of radiation therapy oncology group trial 93-12
-
Glisson B, Scott C, Komaki R, et al. Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. J Clin Oncol 2000;18:2990-2995.
-
(2000)
J Clin Oncol
, vol.18
, pp. 2990-2995
-
-
Glisson, B.1
Scott, C.2
Komaki, R.3
-
8
-
-
0033611522
-
Twice-daily compared with oncedaily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide
-
Turrisi AT, Kim K, Blum R, et al. Twice-daily compared with oncedaily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999;340:265-271.
-
(1999)
N Engl J Med
, vol.340
, pp. 265-271
-
-
Turrisi, A.T.1
Kim, K.2
Blum, R.3
-
9
-
-
0037099617
-
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: Results of the Japan Clinical Oncology Group Study 9104
-
Takada M, Fukuoka M, Kawahara M, et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. J Clin Oncol 2002;20:3054-3060.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3054-3060
-
-
Takada, M.1
Fukuoka, M.2
Kawahara, M.3
-
10
-
-
0027231433
-
Maintenance chemotherapy in small-cell lung cancer: Long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group
-
Giaccone G, Dalesio O, McVie GJ, et al. Maintenance chemotherapy in small-cell lung cancer: long-term results of a randomized trial. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1993;11:1230-1240.
-
(1993)
J Clin Oncol
, vol.11
, pp. 1230-1240
-
-
Giaccone, G.1
Dalesio, O.2
McVie, G.J.3
-
11
-
-
0028149937
-
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer
-
Ihde DC, Mulshine JL, Kramer BS, et al. Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 1994;12:2022-2034.
-
(1994)
J Clin Oncol
, vol.12
, pp. 2022-2034
-
-
Ihde, D.C.1
Mulshine, J.L.2
Kramer, B.S.3
-
12
-
-
0024563045
-
Duration of chemotherapy in small cell lung cancer: A Cancer Research Campaign trial
-
Spiro SG, Souhami RL, Geddes DM, et al. Duration of chemotherapy in small cell lung cancer: a Cancer Research Campaign trial. Br J Cancer 1989;59:578-583.
-
(1989)
Br J Cancer
, vol.59
, pp. 578-583
-
-
Spiro, S.G.1
Souhami, R.L.2
Geddes, D.M.3
-
13
-
-
0024337158
-
A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC)
-
Cerny T, Lind M, Thatcher N, et al. A simple outpatient treatment with oral ifosfamide and oral etoposide for patients with small cell lung cancer (SCLC). Br J Cancer 1989;60:258-261.
-
(1989)
Br J Cancer
, vol.60
, pp. 258-261
-
-
Cerny, T.1
Lind, M.2
Thatcher, N.3
-
14
-
-
0028830167
-
Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood
-
Pettengell R, Woll PJ, Thatcher N, et al. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 1995;13:148-156.
-
(1995)
J Clin Oncol
, vol.13
, pp. 148-156
-
-
Pettengell, R.1
Woll, P.J.2
Thatcher, N.3
-
15
-
-
34547443395
-
-
Buyse M, Staquet M, Sylvester Ret al. Cancer Clinical Trials Methods and Practice. Oxford, UK: Oxford University Press, 2005.
-
Buyse M, Staquet M, Sylvester Ret al. Cancer Clinical Trials Methods and Practice. Oxford, UK: Oxford University Press, 2005.
-
-
-
-
16
-
-
34547473064
-
-
NCI-CTC. National Cancer Institute Cancer Therapy Evaluation Program Common Toxicity Criteria, version 2.0. Available at:, Accessed 1997
-
NCI-CTC. National Cancer Institute Cancer Therapy Evaluation Program Common Toxicity Criteria, version 2.0. Available at: http://ctep. cancer.gov/reporting/ctc.html. Accessed 1997.
-
-
-
-
17
-
-
33845382806
-
Nonparametric estimation for incomplete observation
-
Kaplan EL, Meier P. Nonparametric estimation for incomplete observation. J Am Stat Assos 1958;53:457-481.
-
(1958)
J Am Stat Assos
, vol.53
, pp. 457-481
-
-
Kaplan, E.L.1
Meier, P.2
-
18
-
-
0036788622
-
Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: A prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923
-
Ardizzoni A, Tjan-Heijnen VC, Postmus PE, et al. Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923. J Clin Oncol 2002;20:3947-3955.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3947-3955
-
-
Ardizzoni, A.1
Tjan-Heijnen, V.C.2
Postmus, P.E.3
-
19
-
-
0027521597
-
Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer
-
Arriagada R, Le Chevalier T, Pignon JP, et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. N Engl J Med 1993;329:1848-1852.
-
(1993)
N Engl J Med
, vol.329
, pp. 1848-1852
-
-
Arriagada, R.1
Le Chevalier, T.2
Pignon, J.P.3
-
20
-
-
0021744793
-
The importance of dose intensity in chemotherapy of metastatic breast cancer
-
Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984;2:1281-1288.
-
(1984)
J Clin Oncol
, vol.2
, pp. 1281-1288
-
-
Hryniuk, W.1
Bush, H.2
-
21
-
-
0027322192
-
The impact of dose intensity of standard chemotherapy regimens in extensive stage small cell lung cancer
-
Sheehan RG, Balaban EP, Frenkel EP. The impact of dose intensity of standard chemotherapy regimens in extensive stage small cell lung cancer. Am J Clin Oncol 1993;16:250-255.
-
(1993)
Am J Clin Oncol
, vol.16
, pp. 250-255
-
-
Sheehan, R.G.1
Balaban, E.P.2
Frenkel, E.P.3
-
22
-
-
0036810184
-
An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: Lessons to be drawn
-
Tjan-Heijnen VC, Wagener DJ, Postmus PE. An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn. Ann Oncol 2002;13:1519-1530.
-
(2002)
Ann Oncol
, vol.13
, pp. 1519-1530
-
-
Tjan-Heijnen, V.C.1
Wagener, D.J.2
Postmus, P.E.3
-
23
-
-
0036875583
-
High-dose chemotherapy in small-cell lung cancer
-
Pasini F, Durante E, De Manzoni D, et al. High-dose chemotherapy in small-cell lung cancer. Anticancer Res 2002;22:3465-3472.
-
(2002)
Anticancer Res
, vol.22
, pp. 3465-3472
-
-
Pasini, F.1
Durante, E.2
De Manzoni, D.3
-
24
-
-
0027055377
-
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer
-
Evans WK, Stewart D, Logan D, et al. A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer. Semin Oncol 1992;19:51-56.
-
(1992)
Semin Oncol
, vol.19
, pp. 51-56
-
-
Evans, W.K.1
Stewart, D.2
Logan, D.3
-
25
-
-
0036786077
-
Outpatient intensive chemotherapy for small cell lung cancer: Five years experience of modified 'ICE' ifosfamide carboplatin and etoposide
-
Hand S, Baker J, Smith AP, et al. Outpatient intensive chemotherapy for small cell lung cancer: five years experience of modified 'ICE' ifosfamide carboplatin and etoposide. Clin Oncol (R Coll Radiol) 2002;14:367-371.
-
(2002)
Clin Oncol (R Coll Radiol)
, vol.14
, pp. 367-371
-
-
Hand, S.1
Baker, J.2
Smith, A.P.3
-
26
-
-
0025827446
-
Intensive therapy for smallcell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy
-
Prendiville J, Radford J, Thatcher N, et al. Intensive therapy for smallcell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy. J Clin Oncol 1991;9:1446-1452.
-
(1991)
J Clin Oncol
, vol.9
, pp. 1446-1452
-
-
Prendiville, J.1
Radford, J.2
Thatcher, N.3
-
27
-
-
0027939569
-
Intensive combined-modality therapy in small cell lung cancer
-
Thatcher N, Lorrigan P, Burt P, et al. Intensive combined-modality therapy in small cell lung cancer. Semin Oncol 1994;21:9-22.
-
(1994)
Semin Oncol
, vol.21
, pp. 9-22
-
-
Thatcher, N.1
Lorrigan, P.2
Burt, P.3
-
28
-
-
0027992901
-
Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells
-
Pettengell R, Luft T, Henschler R, et al. Direct comparison by limiting dilution analysis of long-term culture-initiating cells in human bone marrow, umbilical cord blood, and blood stem cells. Blood 1994;84:3653-3659.
-
(1994)
Blood
, vol.84
, pp. 3653-3659
-
-
Pettengell, R.1
Luft, T.2
Henschler, R.3
-
29
-
-
0028588681
-
Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: Effects of storage media, temperature and time
-
Pettengell R, Woll PJ, O'Connor DA, Dexter TM, Testa NG. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: effects of storage media, temperature and time. Bone Marrow Transplant 1994;14:703-709.
-
(1994)
Bone Marrow Transplant
, vol.14
, pp. 703-709
-
-
Pettengell, R.1
Woll, P.J.2
O'Connor, D.A.3
Dexter, T.M.4
Testa, N.G.5
-
31
-
-
0024365557
-
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer
-
Souhami RL, Hajichristou HT, Miles DW, et al. Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer. Cancer Chemother Pharmacol 1989;24:321-325.
-
(1989)
Cancer Chemother Pharmacol
, vol.24
, pp. 321-325
-
-
Souhami, R.L.1
Hajichristou, H.T.2
Miles, D.W.3
-
32
-
-
0032946574
-
High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer
-
Bessho A, Ueoka H, Kiura K, et al. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Anticancer Res 1999;19:693-698.
-
(1999)
Anticancer Res
, vol.19
, pp. 693-698
-
-
Bessho, A.1
Ueoka, H.2
Kiura, K.3
-
33
-
-
0036247773
-
Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: A phase I/II trial
-
Calderoni A, von Briel C, Aebi S, et al. Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial. Lung Cancer 2002;36:321-326.
-
(2002)
Lung Cancer
, vol.36
, pp. 321-326
-
-
Calderoni, A.1
von Briel, C.2
Aebi, S.3
-
34
-
-
0027946388
-
High-dose ifosfamide/carboplatin/ etoposide with autologous hematopoietic stem cell support: Safety and future directions
-
Elias AD, Ayash LJ, Wheeler C, et al. High-dose ifosfamide/carboplatin/ etoposide with autologous hematopoietic stem cell support: safety and future directions. Semin Oncol 1994;21:83-85.
-
(1994)
Semin Oncol
, vol.21
, pp. 83-85
-
-
Elias, A.D.1
Ayash, L.J.2
Wheeler, C.3
-
35
-
-
0036066568
-
Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: Long-term outcome
-
Elias AD, Skarin AT, Richardson P, et al. Dose-intensive therapy for extensive-stage small cell lung cancer and extrapulmonary small cell carcinoma: long-term outcome. Biol Blood Marrow Transplant 2002;8:326-333.
-
(2002)
Biol Blood Marrow Transplant
, vol.8
, pp. 326-333
-
-
Elias, A.D.1
Skarin, A.T.2
Richardson, P.3
-
36
-
-
0032703763
-
Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation
-
Leyvraz S, Perey L, Rosti G, et al. Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small-cell lung cancer: A feasibility study by the European Group for Blood and Marrow Transplantation. J Clin Oncol 1999;17:3531-3539.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3531-3539
-
-
Leyvraz, S.1
Perey, L.2
Rosti, G.3
-
37
-
-
0036972013
-
Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for smallcell lung cancer: Brief report on the results of a phase-I/II trial
-
Oelmann E, Thomas M, Serve H, et al. Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for smallcell lung cancer: brief report on the results of a phase-I/II trial. Oncology 2002;63:248-253.
-
(2002)
Oncology
, vol.63
, pp. 248-253
-
-
Oelmann, E.1
Thomas, M.2
Serve, H.3
-
38
-
-
10244219869
-
Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: An EBMT study
-
Perey L, Rosti G, Lange A, et al. Sequential high-dose ICE chemotherapy with circulating progenitor cells (CPC) in small cell lung cancer: an EBMT study. Bone Marrow Transplant 1996;18(suppl 1):S40-S43.
-
(1996)
Bone Marrow Transplant
, vol.18
, Issue.SUPPL. 1
-
-
Perey, L.1
Rosti, G.2
Lange, A.3
-
39
-
-
0035253367
-
Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: A randomized phase II trial in small-cell lung cancer patients
-
Woll PJ, Thatcher N, Lomax L, et al. Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: a randomized phase II trial in small-cell lung cancer patients. J Clin Oncol 2001;19:712-719.
-
(2001)
J Clin Oncol
, vol.19
, pp. 712-719
-
-
Woll, P.J.1
Thatcher, N.2
Lomax, L.3
-
40
-
-
17444451710
-
A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer
-
Takahashi M, Yoshizawa H, Tanaka H, et al. A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer. Bone Marrow Transplant 2000;25:5-11.
-
(2000)
Bone Marrow Transplant
, vol.25
, pp. 5-11
-
-
Takahashi, M.1
Yoshizawa, H.2
Tanaka, H.3
-
41
-
-
0028925666
-
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer
-
Woll PJ, Hodgetts J, Lomax L, et al. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. J Clin Oncol 1995;13:652-659.
-
(1995)
J Clin Oncol
, vol.13
, pp. 652-659
-
-
Woll, P.J.1
Hodgetts, J.2
Lomax, L.3
-
42
-
-
18344374561
-
Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer
-
Lorigan P, Woll PJ, O'Brien MER, et al. Randomized phase III trial of dose-dense chemotherapy supported by whole-blood hematopoietic progenitors in better-prognosis small-cell lung cancer. J Natl Cancer Inst 2005;97:666-674.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 666-674
-
-
Lorigan, P.1
Woll, P.J.2
O'Brien, M.E.R.3
-
43
-
-
0031917065
-
Effects of granulocytemacrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: A prospective randomized study of 300 patients
-
Steward WP, Von Pawel J, Gatzemeier U, et al. Effects of granulocytemacrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients. J Clin Oncol 1998;16:642-650.
-
(1998)
J Clin Oncol
, vol.16
, pp. 642-650
-
-
Steward, W.P.1
Von Pawel, J.2
Gatzemeier, U.3
|